| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 704.50B | 679.37B | 618.49B | 483.12B | 275.73B |
| Gross Profit | 272.92B | 273.19B | 249.52B | 186.23B | 65.75B |
| EBITDA | 234.94B | 240.43B | 213.06B | 158.72B | 56.26B |
| Net Income | 121.80B | 124.16B | 120.22B | 80.73B | 8.07B |
Balance Sheet | |||||
| Total Assets | 1.63T | 1.44T | 1.36T | 1.21T | 1.09T |
| Cash, Cash Equivalents and Short-Term Investments | 597.10B | 461.32B | 397.01B | 298.23B | 234.87B |
| Total Debt | 326.71B | 266.93B | 209.24B | 240.96B | 242.65B |
| Total Liabilities | 529.05B | 461.11B | 405.65B | 376.73B | 338.35B |
| Stockholders Equity | 1.10T | 977.41B | 949.56B | 829.69B | 756.32B |
Cash Flow | |||||
| Free Cash Flow | 104.26B | 95.34B | 149.35B | 79.21B | -44.24B |
| Operating Cash Flow | 181.28B | 195.39B | 197.67B | 167.73B | 54.60B |
| Investing Cash Flow | -172.10B | -253.14B | -21.27B | -144.43B | -138.98B |
| Financing Cash Flow | 38.56B | -26.87B | -45.63B | -10.94B | 48.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥2.44T | 17.78 | 15.67% | 1.94% | 8.60% | 10.04% | |
71 Outperform | ¥173.34B | 11.00 | ― | 3.40% | 6.49% | -11.12% | |
63 Neutral | ¥241.92B | 19.80 | ― | 2.18% | 8.08% | -27.93% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥233.70B | 12.92 | ― | 1.51% | ― | ― | |
60 Neutral | ¥3.52T | 49.78 | 12.54% | 0.48% | 3.70% | -1.69% | |
51 Neutral | ¥50.11B | 17.63 | ― | ― | 6.93% | ― |